Cherry SE: nine-month revenue falls to €58.9 million
Cherry SE preliminarily reported 9M 2026 revenue of €58.9 million and delayed its quarterly statement. Argand has committed up to €5 million in liquidity.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Cherry SE preliminarily estimated revenue for the first nine months of 2026 at €58.9 million, against €70.7 million a year earlier. Adjusted EBITDA came in at minus €6.9 million, compared with minus €11.9 million a year ago, which excluded a €7 million one-off charge.
The company postponed its quarterly statement because the audit of its 2025 financial statements is not yet finished. It also secured a liquidity commitment of up to €5 million from Argand, valid until December 31, 2026. According to EQS, which distributed the company's release, Digital Health has been classified as discontinued.
why it matters
Revenue is falling as the company clears sales channels and demand for peripherals weakens, while the loss narrows thanks to a 7.4 percentage point gain in gross margin. The Argand commitment reduces near-term liquidity risk, but the delayed reporting and unfinished audit may weigh on investor sentiment. A sale of Digital Health, if completed, would change the company's business mix.
tags
instruments
sources
- Cherry SE (C3RY) 9M26 Rev €58.9M; Adj. EBITDA -€6.9M; Gets Up To €5M Support — eqs-news.com, 19 October 2026 at 14:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗